Coricidin Hbp Chest Congestion And Cough Capsule, Gelatin Coated
NDC Package 11523-7158-2
Package Information
Coricidin Hbp Chest Congestion And Cough (dextromethorphan hydrobromide and guaifenesin) capsules is do not exceed recommended doseadults and children 12 years and over: 1 or 2 softgels every 4 hours, not more than 12 softgels in 24 hours children under 12 years of age: ask a doctor. This formulation utilizes a capsule, gelatin coated delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 11523-7158 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1111663 - dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule
- RxCUI: 1111663 - dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 11523 - Bayer Healthcare Llc.
- 11523-7158 - Coricidin Hbp Chest Congestion And Cough
- 11523-7158-2 - 2 BLISTER PACK in 1 CARTON / 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK
- 11523-7158 - Coricidin Hbp Chest Congestion And Cough
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11523-7158-2 identifies a specific commercial package of 2 blister pack in 1 carton / 10 capsule, gelatin coated in 1 blister pack of Coricidin Hbp Chest Congestion And Cough, a human over the counter drug labeled by Bayer Healthcare Llc.. This capsule, gelatin coated is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on August 31, 2000. The current certification is valid through December 31, 2026.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11523715802. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.